CRNT
Ceragon Networks Ltd
2.20$
+3.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.9% | -4.1% | +4.4% | +6.1% | +8.7% | +0.3% | -5.1% | -0.4% | -3.0% | -3.1% | +2.1% | |
| – | -2.6% | -6.1% | +5.7% | +8.2% | +11.6% | -2.8% | -7.7% | +0.5% | -4.4% | -5.0% | +2.9% | |
| – | -16.9% | +1.9% | -8.6% | +29.3% | +3.8% | -21.6% | +5.5% | +47.1% | -10.7% | +2.1% | -11.2% | |
| – | -16.9% | +1.9% | -8.6% | +29.3% | +3.8% | -21.6% | +5.5% | +47.1% | -10.7% | +2.1% | -11.2% | |
| – | +8.9% | +0.9% | +13.7% | -6.9% | +25.9% | +6.9% | -24.2% | -9.8% | -11.0% | -5.3% | +7.3% | |
| – | -1.8% | -11.3% | -2.5% | +0.5% | -0.2% | +4.4% | -3.8% | -2.5% | +5.4% | -8.3% | +5.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | +42.5% | +0.0% | +0.0% | -0.4% | +0.0% | +0.0% | |
| – | +75.7% | -0.8% | +1.5% | +0.5% | +1.2% | +32.8% | +0.6% | +1.1% | +2.3% | +3.0% | +2.8% | |
| – | -3.6% | -8.0% | +2.8% | +2.9% | +11.6% | +0.3% | -12.6% | -1.2% | -6.8% | -5.8% | +4.3% | |
| – | -1.7% | -9.4% | +5.8% | +3.7% | +14.7% | -0.6% | -16.4% | +3.1% | -7.4% | -6.4% | +5.6% | |
| – | -11.5% | -6.2% | -7.7% | -11.2% | +0.4% | +0.6% | -14.5% | +43.4% | -33.8% | -8.5% | -23.7% | |
| – | +1.8% | -15.7% | +19.3% | +11.9% | +20.8% | -2.8% | -16.7% | -5.6% | +1.6% | -7.4% | +13.1% | |
| – | +2.7% | +0.7% | +6.3% | +9.5% | +5.8% | +0.4% | +2.9% | +0.2% | +0.4% | -0.7% | +0.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.5% | +3.0% | +0.4% | +0.5% | +1.9% | -1.4% | +0.8% | +2.5% | +0.8% | -1.9% | +0.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.